[ad_1] Shares of Glenmark Pharma Ltd. gained up to 4% on Tuesday, December 10, following first clinical data from the Phase 1 studi of a cancer treating drug. Company Value Change %Change Glenmark in an exchange filing said that the first clinical data from Phase 1 study of Trispecific TREAT Antibody, ISB 2001, showed a […]
Headline
Tag: Glenmark Pharma blood cancer drug trial
Back To Top